Home
Home » companies

Biomarin

BioMarin Gains on Prospects for Experimental Cancer Drug

BioMarin Gains on Prospects for Experimental Cancer Drug
Bloomberg

BioMarin abstract showed impressive anti-tumor activity, says Leerink

BioMarin abstract showed impressive anti-tumor activity, says Leerink
Yahoo/Fly on the Wall

Orphan Drug Biotechs Do It Best

Orphan Drug Biotechs Do It Best
Motley Fool

These 4 'High-Potential' Biotech Stocks Could Outperform In 2013

These 4 'High-Potential' Biotech Stocks Could Outperform In 2013
Seeking Alpha

BioMarin submits CTA for BMN-190 for Batten disease

BioMarin submits CTA for BMN-190 for Batten disease
Yahoo/Fly on the Wall

BioMarin: Gains To Continue As Pipeline Progress Is Realized

BioMarin: Gains To Continue As Pipeline Progress Is Realized
Seeking Alpha

BioMarin says it will continue studies of late-onset Pompe disease drug candidate BMN-701

BioMarin says it will continue studies of late-onset Pompe disease drug candidate BMN-701
Yahoo/AP

4 Biotech Stock Stars Losing Their Luster

4 Biotech Stock Stars Losing Their Luster
TheStreet.com Stockpkr

BioMarin Earnings: An Early Look

BioMarin Earnings: An Early Look
Motley Fool

Biomarin: This Mid-Cap Pharmaceutical is a Prime Takeover Target

Biomarin: This Mid-Cap Pharmaceutical is a Prime Takeover Target
Motley Fool